Walmark

Sector: pharmaceutical industry

Client: ATERNUS

Year: 2015

Deal value: confidential

COPRIN acted as exclusive financial advisor to ATERNUS and its shareholders, founders of WALMARK, in relation to disposal of their remaining 50% share on voting rights in WALMARK to the owner of other 50%, fund managed by Mid Europa Partners („MEP“), one of the largest western-type private equity funds focused on Central and Eastern Europe.

This second mandate from the same client follows successful assignment completed in December 2012, when first 50% was sold to MEP and de facto 50/50 joint venture with MEP was set up.

After almost three years of cooperation with MEP, founding shareholders of Walmark decided to pursue other investment and life opportunities and important transaction was completed after complex negotiations in mid-2015. More info to be found in press release
here.